Solis, Glo-an B.
HRN: 21-98-05 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/24/2022
CEFUROXIME 500MG (TAB)
10/24/2022
10/30/2022
PO
500mg
BID
Thickly Msaf, Episiorhaphy
Waiting Final Action
Indication: Empiric Type of Infection: URTISkin & Soft TissueIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes